Thrombocytopenia represents a risk for deterioration of liver function after radiofrequency ablation in patients with hepatocellular carcinoma
Background/AimsWe evaluated changes in liver function parameters and risk factors for the deterioration of liver function 12 months after percutaneous radiofrequency ablation (RFA) therapy in patients with hepatocellular carcinoma (HCC).MethodsThe subjects in this retrospective study comprised 102 p...
Main Authors: | Hyun Seok Lee, Soo Young Park, Sung Kook Kim, Young Oh Kweon, Won Young Tak, Chang Min Cho, Seong Woo Jeon, Min Kyu Jung, Hyun Gu Park, Dong Wook Lee, So Young Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2012-09-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-18-302.pdf |
Similar Items
-
Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation
by: Jung Guen Cha, et al.
Published: (2020-01-01) -
Effectiveness of Injecting Cold 5% Dextrose into Patients with Nerve Damage Symptoms during Thyroid Radiofrequency Ablation
by: Min Kyoung Lee, et al.
Published: (2020-06-01) -
Tract ablation after radiofrequency ablation to prevent viable tumor cell adhesion to the needle electrode
by: Su Jung Ham, et al.
Published: (2020-01-01) -
Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation
by: Hyun Ah Chung, et al.
Published: (2016-01-01) -
CT-based quantitative evaluation of the efficacy after radiofrequency ablation in patients with benign thyroid nodules
by: Yangsean Choi, et al.
Published: (2020-01-01)